Research. Advocacy. Support.

We advance ovarian cancer research while supporting women and their families.

Learn more about OCRFA

Know Your Risks

About 20 to 25 percent of women diagnosed with ovarian cancer have a hereditary tendency to develop the disease.

Learn about your risks

Risk Factors

Many factors can increase or decrease a woman's risk of developing ovarian cancer.

Increases Risk

  • Family history of breast, ovarian or colon cancer
  • Genetic mutations like BRCA
  • Post-menopausal
  • Increased age

Decreases Risk

  • Pregnancy
  • Breastfeeding
  • Use of oral contraceptives

Know the Symptoms

  • Bloating
  • Difficulty Eating
  • Pelvic / Abdominal Pain
  • Urinary Frequency

If these symptoms occur for more than 2 weeks and these symptoms are new or unusual for you, see a gynecologist and ask about ovarian cancer. Research shows that seeing a gynecologic oncologist for surgery and treatment significantly improves outcomes.

Share Your #OvarianStory

Every ovarian cancer survivor's voice has power. Hear Emily's story and use #OvarianStory to share your own.

Donate

Latest News

  • OCRFA Funded Research Identifies Mechanism Underlying Ovarian Cancer Development

    (November 22, 2017) A recent paper published in the Journal of Clinical Investigation reports that a subset of ovarian cancers reduce the expression of a critical gene involved in recycling the cells’ proteins, known as ubiquitin B (UBB). Silencing the expression of a closely related gene, also in the ubiquitin family, that performs an identical… More

    Posted
  • New Research Indicates that High Grade Serous Ovarian Carcinomas Originate in the Fallopian Tubes

    (October 30, 2017) Until recently, it was thought that high-grade serous ovarian carcinomas (HGSOCs) arose from the ovarian surface epithelium, but recent data from two studies published in Nature Communications suggest that all high grade serous ovarian cancers do in fact originate in the fallopian tube. These findings have implications for ovarian cancer detection and… More

    Posted
  • White Blood Cells Found in High Grade Ovarian Cancer May Point to Survival Outcomes

    (October 20, 2017) An international, large scale study may have found a link between high-grade ovarian cancer and a type of white blood cell known as a tumor-infiltrating lymphocyte. Recently published in JAMA Oncology, the article from the Ovarian Tumor Tissue Analysis Consortium discussed the study, which involved about 5,500 patients, 3,196 of whom had… More

    Posted

Upcoming Events